Global Information
회사소개 | 문의

제세동기 시장 : 성장, 동향, 예측(2019-2024년)

Defibrillator Market - Growth, Trends, and Forecast (2019 - 2024)

리서치사 Mordor Intelligence LLP
발행일 2019년 03월 상품 코드 659348
페이지 정보 영문 110 Pages
가격
US $ 4,250 ₩ 4,859,000 PDF by E-mail (Single User License)
US $ 4,500 ₩ 5,145,000 PDF by E-mail (Team License: Up to 5 Users)
US $ 7,000 ₩ 8,003,000 PDF by E-mail (Site License)
US $ 8,750 ₩ 10,004,000 PDF by E-mail (Corporate License)


제세동기 시장 : 성장, 동향, 예측(2019-2024년) Defibrillator Market - Growth, Trends, and Forecast (2019 - 2024)
발행일 : 2019년 03월 페이지 정보 : 영문 110 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 제세동기(Defibrillator) 시장을 조사했으며, 전체적인 시장 동향, 제품 및 지역별 동향, 시장 성장 영향요인, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 시장 정의

제2장 조사 방법

제3장 주요 요약

제4장 주요 예측

제5장 시장 개요

  • 현재의 시장 시나리오
  • 파이프라인 분석
  • Porter's Five Forces 분석
    • 공급업체의 협상력
    • 소비자의 협상력
    • 신규 진출기업의 위협
    • 대체 제품과 서비스의 위협
    • 업계 내 경쟁
  • 규제 시나리오

제6장 성장 촉진요인 및 저해요인, 기회, 과제 분석(DROC)

  • 시장 성장 촉진요인
    • 증가하고 있는 심혈관 질환 이환율
    • 제세동기 기술 발전
    • 제세동기 교육과 계몽 활동
  • 시장 성장 저해요인
    • 비용이 높은 제세동기
    • 엄격한 규제 구조
  • 시장 기회
  • 주요 과제

제7장 시장 세분화

  • 최종사용자별
    • 병원
    • 응급처치
    • 가정간호
    • 기타
  • 제품별
    • 삽입형 제세동기(ICD)
    • 체외 제세동기(ED)
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제8장 경쟁 구도

  • 기업 인수합병(M&A) 분석
  • 합의, 협력, 제휴
  • 신제품 발매

제9장 주요 기업

  • Boston Scientific Corporation
  • Cardiac Science
  • Defibtech LLC
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic
  • Nihon Kohden
  • Physio-Control Inc.
  • Abbott(St. Jude Medical, LLC)
  • ZOLL Medical Corporation

제10장 시장 전망

LSH 18.07.13

Market Overview

The growth of the defibrillator market can be attributed to factors such as technological advancements in the field of defibrillators and training and awareness programs for defibrillators. According to the American Heart Association's research program, cardiovascular diseases are listed as the primary cause of deaths, and accounted for nearly 836,546 deaths in the United States. The deaths related to cardiovascular diseases are higher when compared to deaths related to all forms of cancer and chronic lower respiratory diseases combined. As per the American Heart Association, cardiovascular disease is the leading cause of death, globally, accounting for more than 17.9 million deaths per year in 2015, a number that is expected to grow to more than 23.6 million by 2030. Hence, the increase in prevalence of cardiovascular diseases is expected to drive the market growth.

Scope of the Report

Defibrillator is a life-saving device that helps deliver a therapeutic shock to a patient's heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. In the United States, approximately 300,000 out-of-hospital cardiac arrests occur each year. Supportive government policies in developed countries may help increase the availability and access of defibrillators, which will likely further boost the market growth over the forecast period.

Key Market Trends

Implantable Cardioverter Defibrillator(ICD) Spearheaded the Defibrillator Market

The implantable cardioverter defibrillator (ICD) segment accounted for the largest share in the global market. The ICDs are of three major types, namely transvenous ICDs, subcutaneous ICDs, and CRT with pacemaker and ICD function. The transvenous and subcutaneos ICDs are expected to exhibit the fastest growth rate over the forecast period, owing to the rising technological advancements, increasing R&D, and benefits associated with these ICDs. The overall ICD segment contributes for the largest market share, owing to the rising integration of multiple technological capabilities in a single device, such as defibrillators and pacemakers. In addition, the efficacy of these devices to manage arhythmias for a prolonged period is expected to drive the segment growth over the forecast period.

North America Dominated the Global Defibrillator Market

Cardiovascular diseases, listed as the underlying cause of death, account for nearly 836,546 deaths (about 1 of every 3 deaths) in the United States. Thus, the increasing prevalence of cardiovascular diseases in the region is expected to drive the growth of this market over the forecast period. In 2017, the Department of Health and Human Services (HHS), along with a number of public and private partners, launched the Million Hearts initiative that aims to prevent one million heart attacks and strokes. All the aforementioned factors are expected to boost the market growth.

Competitive Landscape

The major players operating in the defibrillators market are Boston Scientific Corporation, Koninklijke Philips NV., Medtronic, Nihon Kohden Corporation, and Abbott Laboratories. The key strategies adopted by the major market players are acquisitions and mergers, new product developments, geographical expansions, and enhanced marketing strategies.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases
    • 4.2.2 Technological Advancements in the Field of Defibrillators
    • 4.2.3 Training and Awareness Programs about Defibrillators
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Defibrilators
    • 4.3.2 Stringent Regulatory Framework
  • 4.4 Industry Attractiveness Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Implantable Cardioverter Defibrillator
      • 5.1.1.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
      • 5.1.1.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
      • 5.1.1.3 CRT with Pacemaker and ICD Function (CRT-D)
    • 5.1.2 External Defibrillator (ED)
      • 5.1.2.1 Automated External Defibrillator (AEDs)
      • 5.1.2.1.1 Semi-automated External Defibrillators
      • 5.1.2.1.2 Fully-automated External Defibrillators
      • 5.1.2.2 Manual External Defibrillator
      • 5.1.2.3 Wearable Cardioverter Defibrillators (WCDs)
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Emergency Care
    • 5.2.3 Home Care
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 United Kingdom
      • 5.3.2.2 Germany
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cardiac Science Corporation
    • 6.1.4 Defibtech LLC
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 LivaNova PLC
    • 6.1.7 Medtronic plc.
    • 6.1.8 NIHON KOHDEN CORPORATION
    • 6.1.9 Physio-Control Inc.
    • 6.1.10 ZOLL Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q
 
BCC Research